Craig Leonardi

A phase I/II randomized, double‐blind, placebo‐controlled, dose‐ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis

Craig Leonardi, RR Stoltz, PF Pierce et al. · Journal of the European Academy of Dermatology and Venereology · 2005 · 71 citations

Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris.

Joel Schlessinger, Alan Menter, Michael H. Gold et al. · PubMed · 2007 · 48 citations

Clin/ra Gel, Medicine, Clinical Safety +10

Safety and Tolerability of Ixekizumab: Integrated Analysis of Injection-Site Reactions from 11 Clinical Trials.

Neil H. Shear, C. Paul, Andrew Blauvelt et al. · PubMed · 2018 · 23 citations

Drug Hypersensitivity, Autoimmune Disease, Medicine +13

Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials.

Kim Papp, Jennifer Cather, Craig Leonardi et al. · PubMed · 2016 · 22 citations

The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2)

Alan Menter, Nehal N. Mehta, Mark Lebwohl et al. · Journal of Drugs in Dermatology · 2020 · 20 citations · Full text